GA Ramirez, M Gerosa, C Bellocchi, D Arroyo-Sánchez… - Biomolecules, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease (COVID- 19) has spread pandemically with high rates of morbidity and mortality. COVID-19 has also …
Importance During the COVID-19 pandemic, stabilized COVID-19–positive patients were discharged to skilled nursing facilities (SNFs) to alleviate hospital crowding. These …
HJ Appaneal, KL LaPlante, VV Lopes, C Martin… - Infectious Diseases and …, 2024 - Springer
Introduction Limited data exist regarding real-world utilization of nirmatrelvir/ritonavir. We identified predictors of nirmatrelvir/ritonavir use among Veterans Affairs (VA) outpatients …
To the Editor The Agency for Healthcare Research and Quality describes the USPSTF as follows:“The USPSTF works to improve the health of people nationwide by making …
Antiviral therapeutics for COVID-19 in nonhospitalized patients prevent progression to severe illness, hospitalization, and death. Despite their proven benefit, utilization of these …
Importance Nursing home residents continue to bear a disproportionate share of COVID-19 morbidity and mortality, accounting for 9% of all US COVID-19 deaths in 2023, despite …
L Yan, D Bui, Y Li, N Rajeevan… - Clinical Infectious …, 2024 - academic.oup.com
Background Nirmatrelvir-ritonavir is recommended for persons at risk for severe coronavirus disease 2019 (COVID-19) but remains underutilized. Information on which eligible groups …
K Penrose, A Srivastava, Y Shen… - Infectious Diseases and …, 2024 - Springer
Introduction Oral antiviral medications are important tools for preventing severe COVID-19 outcomes. However, their uptake remains low for reasons that are not entirely understood …
Regarding monoclonal antibody treatment, there were issues with staffing competency in placing a peripheral intravenous line, infusions that required an extended monitoring period …